EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients

María Belén Giorello, Leandro Marcelo Martinez, Francisco Raúl Borzone, María Del Rosario Padin, María Florencia Mora, Ina Sevic, Laura Alaniz, María de Luján Calcagno, Hernán García-Rivello, Alejandra Wernicke, Vivian Labovsky, Norma Alejandra Chasseing

Frontiers in Cell and Developmental Biology · 31.08.2023 · 11

DOI: 10.3389/fcell.2023.1250869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 31.08.2023. Verfasst von María Belén Giorello und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunohematología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bone metastasis is one of the causes that mainly decrease survival in patients with advanced breast cancer. Therefore, it is essential to find prognostic markers for the occurrence of this type of metastasis during the early stage of the disease. Currently, cancer-associated fibroblasts, which represent 80% of the fibroblasts present in the tumor microenvironment, are an interesting target for studying new biomarkers and developing alternative therapies. This study evaluated the prognostic significance of the CD105 expression in cancer-associated fibroblasts in early breast cancer patients.

Methods

Immunohistochemistry was used to assess CD105 expression in invasive ductal breast carcinomas (n = 342), analyzing its association with clinical and pathological characteristics.

Results

High CD105 expression in cancer-associated fibroblasts was associated with an increased risk of metastatic occurrence ( p = 0.0003), particularly bone metastasis ( p = 0.0005). Furthermore, high CD105 expression was associated with shorter metastasis-free survival, bone metastasis-free survival, and overall survival ( p = 0.0002, 0.0006, and 0.0002, respectively). CD105 expression also constituted an independent prognostic factor for metastasis-free survival, bone metastasis-free survival, and overall survival ( p = 0.0003, 0.0006, and 0.0001, respectively).

Discussion

The high CD105 expression in cancer-associated fibroblasts is an independent prognostic marker for bone metastasis in early breast cancer patients. Therefore, the evaluation of CD105(+) CAFs could be crucial to stratify BCPs based on their individual risk profile for the development of BM, enhancing treatment strategies and outcomes.

Schlagwörter

Stichwörter der Autor:innen

CD105bone metastasisbreast cancercancer-associated fibroblastsprognosis factor

Autor:innen und Institutionen

  • Laboratorio de Inmunohematología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, United States.
  • Departamento de Anatomía Patológica, Hospital Italiano, Buenos Aires, Argentina.
  • Laboratorio de Microambiente Tumoral, Centro de Investigaciones Basicas y Aplicadas (CIBA), Junín, Argentina.
  • Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.

Zitieren

APA

Giorello, M. B., Martinez, L. M., Borzone, F. R., Padin, M. D. R., Mora, M. F., Sevic, I., Alaniz, L., Calcagno, M. L., García-Rivello, H., Wernicke, A., Labovsky, V., & Chasseing, N. A. (2023). CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1250869

Vancouver

Giorello MB, Martinez LM, Borzone FR, Padin MDR, Mora MF, Sevic I, et al. CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1250869

BibTeX
@article{Giorello2023,
  author = {Giorello, María Belén and Martinez, Leandro Marcelo and Borzone, Francisco Raúl and Padin, María Del Rosario and Mora, María Florencia and Sevic, Ina and Alaniz, Laura and Calcagno, María de Luján and García-Rivello, Hernán and Wernicke, Alejandra and Labovsky, Vivian and Chasseing, Norma Alejandra},
  title = {CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1250869}
}
Kostenlos starten →